Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (Above or equal to 65)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027
2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2021 Versus 2027
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2027)
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2016-2021
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2027)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2016-2021
2.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2027)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturers
3.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Sales
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Type
3.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 MSD
4.1.1 MSD Corporation Information
4.1.2 MSD Description, Business Overview
4.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
4.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Product
4.1.6 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
4.1.7 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Area
4.1.8 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Sales Channel
4.1.9 MSD Recent Development
4.2 Sanofipasteur
4.2.1 Sanofipasteur Corporation Information
4.2.2 Sanofipasteur Description, Business Overview
4.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
4.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Product
4.2.6 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
4.2.7 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Area
4.2.8 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Sales Channel
4.2.9 Sanofipasteur Recent Development
4.3 CDIBP
4.3.1 CDIBP Corporation Information
4.3.2 CDIBP Description, Business Overview
4.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
4.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Product
4.3.6 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
4.3.7 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Area
4.3.8 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Sales Channel
4.3.9 CDIBP Recent Development
5 Breakdown Data by Type
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2027)
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2027)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2027)
5.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2027)
6.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021)
6.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2027)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021)
6.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2027)
6.3 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
7.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
7.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2027)
7.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2027)
7.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
9 Europe
9.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
9.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
9.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2027)
9.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2027)
9.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
9.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
10 Latin America
10.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
10.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2027)
10.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2027)
10.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
10.4 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
11.4 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials and Upstream Suppliers
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Clients Analysis
12.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channel and Sales Model Analysis
12.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
13 Market Dynamics
13.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
13.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities
13.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
13.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Single Dose Vial
Table 3. Major Manufacturers of Pre-filled Syringe
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 VS 2027
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2022-2027) & (K Dose)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2016-2021) & (K Dose)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer (2016-2021)
Table 12. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 13. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturer (2016-2021)
Table 14. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2016-2021) & (US$/Dose)
Table 15. Ranking of Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
Table 18. 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 20. Date of International Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. MSD Corporation Information
Table 23. MSD Description and Business Overview
Table 24. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 25. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 26. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Product
Table 27. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Application
Table 28. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 29. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 30. MSD Recent Development
Table 31. Sanofipasteur Corporation Information
Table 32. Sanofipasteur Description and Business Overview
Table 33. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 34. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 35. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Product
Table 36. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Application
Table 37. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 38. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 39. Sanofipasteur Recent Development
Table 40. CDIBP Corporation Information
Table 41. CDIBP Description and Business Overview
Table 42. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 43. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 44. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Product
Table 45. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Application
Table 46. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Geographic Area
Table 47. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) and Market Share by Sales Channel
Table 48. CDIBP Recent Development
Table 49. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027) & (K Dose)
Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027) & (K Dose)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 57. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 58. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 59. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 60. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 61. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 62. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 63. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 64. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2022-2027) & (K Dose)
Table 65. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2027) & (US$ Million)
Table 66. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 67. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 68. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 69. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 70. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 71. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 72. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 73. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 74. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 75. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 76. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 77. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 79. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 80. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 81. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 82. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 83. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 84. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 85. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 86. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 87. 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials, Industry Status and Trend
Table 88. 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials and Upstream Suppliers
Table 89. 23-Valent Pneumococcal Polysaccharide Vaccine Clients Status and Trend
Table 90. 23-Valent Pneumococcal Polysaccharide Vaccine Typical Clients
Table 91. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
Table 92. Key Drivers: Impact Analysis (2022-2027)
Table 93. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Table 94. 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities
Table 95. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 96. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 97. 23-Valent Pneumococcal Polysaccharide Vaccine Porter's Five Forces Analysis
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. For Children (2-10) Examples
Figure 7. For Person (10-64) Examples
Figure 8. For The Old (Above or equal to 65) Examples
Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027 (K Units)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2016-2027)
Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2027)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturer in 2020
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2016-2027)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2016-2027)
Figure 20. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2016-2027)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2016-2027)
Figure 23. 23-Valent Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 24. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027 (US$ Million)
Figure 25. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Figure 26. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 27. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027 (US$ Million)
Figure 28. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2027)
Figure 29. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2027)
Figure 30. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Figure 31. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2027)
Figure 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2027)
Figure 35. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Figure 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 37. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 38. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2027)
Figure 39. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Figure 40. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Figure 41. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 42. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 43. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2027)
Figure 44. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2027)
Figure 45. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Figure 46. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 47. 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials by Region in 2020
Figure 49. 23-Valent Pneumococcal Polysaccharide Vaccine Distribution Channels
Figure 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Percentage 2016-2027: Online Sales VS Offline Sales
Figure 52. Porter's Five Forces Analysis
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs